 CAMBRIDGE, Mass., April 27, 2021 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced three digital presentations at the American Society of Gene Cell Therapy ASGCT 2021 Virtual Annual Meeting taking place May 11-14. The presentations will cover data supporting use of the companys platform for antibody gene therapy, a summary of previously released preclinical data from the hemophilia A program and insight into ceDNA construct engineering for factor VIII. 